Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection.

Subbotin V, Sun H, Aitouche A, Salam A, Valdivia LA, Fung JJ, Starzl TE, Rao AS. Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection. Transplantation. 1999 May 27; 67(10):1295-300.

View in: PubMed

collapse authors with profiles